Publication date: July 2026 Source: Indian Journal of Tuberculosis, Volume 73, Issue 3 Author(s): Sarah Iribarren, Javier Roberti, Alfie Aguilar-Vidrio, Barry Lutz, Fernando Rubinstein
Patient experiences and motivations in tuberculosis treatment: Insights from a digital adherence technology trial. // Indian Journal of Tuberculosis. – URL: https://www.sciencedirect.com/science/article/pii/S0019570726000879?dgcid=rss_sd_all
Patient experiences and motivations in tuberculosis treatment: Insights from a digital adherence technology trial. Indian Journal of Tuberculosis. https://www.sciencedirect.com/science/article/pii/S0019570726000879?dgcid=rss_sd_all
“Patient experiences and motivations in tuberculosis treatment: Insights from a digital adherence technology trial.” Indian Journal of Tuberculosis.
@article{article94077,
title = {Patient experiences and motivations in tuberculosis treatment: Insights from a digital adherence technology trial},
journal = {Indian Journal of Tuberculosis},
url = {https://www.sciencedirect.com/science/article/pii/S0019570726000879?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...